10 clinical trials found.
-
Risk factors for sudden unexplained death in epilepsy (SUDEP)
The purpose of this multi-site study is to build a research registry – the “North American SUDEP Registry (NASR)” to assess the risk factors and pathophysiologic ...Phase
Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
Multicenter Study of Epilepsy Surgery Long Term Outcomes Mortality
The Multicenter Study of Epilepsy Surgery – Long Term Outcomes Mortality study aims to examine the various aspects of epilepsy surgery outcomes after more than 10 ...Phase N/A TRIAL ROLE: Sub Investigator
-
Mechanisms and Enhancement of Learning During Sleep
The purpose of this study is to understand how sleep affects learning and memory. We are looking to enroll patients with epilepsy. Often, patients with ...Phase
Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
Expanded Access Program for Lorcaserin (Belviq)
The purpose of this extended access program is to provide continued access to lorcaserin for Dravet syndrome and other epilepsy patients who were being treated ...Phase N/A TRIAL ROLE: Sub Investigator
-
STK-001-DS-501 - An Open-Label Extension Study for Patients with Dravet Syndrome who Previously Participated in Studies of STK 001
The purpose of this research study is to look at a possible new therapy for Dravet syndrome, called STK-001. Dravet syndrome is a severe form ...Phase
TRIAL ROLE: Sub Investigator
-
Studies of Patients with Implanted Intracranial Electrodes
This research is being done to study different methods for mapping the areas of the human brain responsible for speech, language, hearing, vision, sensation, movement ...Phase N/A TRIAL ROLE: Sub Investigator
-
Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures
This is a clinical research study of an investigational new drug device combination product of Staccato and alprazolam inhalation powder, called “Staccato ® alprazolam”. Staccato alprazolam ...Phase
TRIAL ROLE: Sub Investigator
-
Randomized Double-blind Placebo-Controlled Multicenter Phase 3 Study to Evaluate the Safety Tolerability and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures
In this research a study drug named XEN1101 is being tested for the treatment of seizures. XEN1101 is a study drug because its safety, effectiveness ...Phase
TRIAL ROLE: Sub Investigator
-
A Clinical Research Study for Children Teens and Young Adults Diagnosed With Dravet Syndrome The Skyline Study
The Skyline Study is a Phase 3 clinical research study of an investigational medication for children, teens, and young adults diagnosed with Dravet syndrome who ...Phase
TRIAL ROLE: Sub Investigator
-
GWEP19022 - A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated with Epidiolex Cannabidiol Oral Solution
The purpose of this research study is to study the long-term effects of Epidiolex on the liver.Phase N/A TRIAL ROLE: Sub Investigator
